Vivo Capital »

Editas Medicine shares owned by Vivo Capital

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by Vivo Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 3.6M 3.24

More positions owned by Vivo Capital

Trevi Therapeutics Common (TRVI)
Praxis Precision Medicines Common (PRAX)
Erasca Common (ERAS)
Arrivent BioPharma Common (AVBP)
Abivax SA - Sponsored Ads (ABVX)
Tango Therapeutics Common (TNGX)
Corvus Pharmaceuticals Common (CRVS)
Bright Minds Biosciences Common (DRUG)
Sinovac Biotech SHS
Tenax Therapeutics Common (TENX)
Aclaris Therapeutics Common (ACRS)
Dyne Therapeutics Common (DYN)
Dianthus Therapeutics Common (DNTH)
Alto Neuroscience Common (ANRO)
DBV Technologies SA Sponsored Ads (DBVT)

View all positions for Vivo Capital

Top funds holding Editas Medicine

TCG Crossover Management
BlackRock
ADAR1 Capital Management
RA Capital Management
Commodore Capital
Vanguard Capital Management
Paradigm Biocapital Advisors
Opaleye Management
Vanguard Portfolio Management
Woodline Partners
Vivo Capital
Goldman Sachs Group
Geode Capital Management
Renaissance Technologies
Logos Global Management

View all funds holding Editas Medicine